Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
How Does The Market Size Of The Allergic Rhinitis Industry Compare Between 2025 And 2029?
The allergic rhinitis market size has shown steady expansion in recent years. This market is expected to increase from $15.22 billion in 2024 to $15.69 billion in 2025, reflecting a compound annual growth rate (CAGR) of 3.1%. The historical growth in this sector can be attributed to factors such as allergen exposure, environmental changes, heightened public awareness, increasing pollution, ongoing research and developments in allergic rhinitis, and rising disposable incomes.
The allergic rhinitis market is projected to experience consistent expansion over the upcoming years. This market is anticipated to reach “$18.53 billion by 2029, expanding at a compound annual growth rate (CAGR) of 4.3%.” Factors contributing to this growth during the forecast period include the increasing demand for preventive treatments, a growing aging population, ongoing urbanization, and rising healthcare spending. Key trends identified for the forecast period encompass advancements in biologics and monoclonal antibodies, the adoption of digital health solutions, enhanced allergen avoidance strategies, increased focus on pediatric allergic rhinitis, and developments in allergen detection technology.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12926&type=smp
What Are The Drivers Pushing New Developments In The Allergic Rhinitis Market?
The allergic rhinitis market is projected to experience growth driven by high levels of air pollution and climate change in the coming period. Air pollution signifies the existence of detrimental compounds in the Earth’s atmosphere, which can negatively impact human well-being, the ecosystem, and the quality of ambient air. Climate change denotes lasting shifts in the planet’s climate patterns, covering temperature, rainfall, and various other climatic elements. There is growing recognition that air pollution acts as a crucial environmental contributor to both the occurrence and intensification of allergic rhinitis, underscoring the complex connection between air quality and respiratory well-being. For example, in August 2024, the United States Environmental Protection Agency, a US-based Government agency, stated that approximately 66 million tons of pollutants were discharged into the atmosphere throughout the United States in 2023. Consequently, elevated levels of air pollution and climate change are significant drivers for the allergic rhinitis market.
What Are The Key Segments In The Allergic Rhinitis Market?
The allergic rhinitismarket covered in this report is segmented –
1) By Type: Seasonal Allergic Rhinitis; Perennial Allergic Rhinitis; Occupational Allergic Rhinitis
2) By Treatment: Antihistamines; Corticosteroids; Immunotherapy; Decongestants; Other Treatments
3) By Test: Skin Test; IgE Radioallergosorbent (RAST) Test; Complete Blood Count
4) By Route Of Administration: Oral; Nasal; Other Route Of Administration
5) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Stores
Subsegments:
1) By Seasonal Allergic Rhinitis: Pollen Allergy; Mold Allergy
2) By Perennial Allergic Rhinitis: Dust Mite Allergy; Pet Allergy; Mold Allergy
3) By Occupational Allergic Rhinitis: Chemical Allergens; Biological Allergens
Which Trends Are Impacting The Allergic Rhinitis Market?
Leading firms within the allergic rhinitis market are creating advanced drugs to maintain their competitive standing. An example of this is the August 2022 announcement by Hikma Pharmaceuticals PLC, a UK pharmaceutical company, and Glenmark Specialty S.A., a Switzerland-based pharmaceutical company, regarding the United States Food and Drug Administration (FDA), a US federal agency, granting approval for their Ryaltris product. Ryaltris stands as the initial fixed-dose combination medication designed to address both nasal and ocular indicators of seasonal allergic rhinitis, delivered through an accessible nasal spray for individuals aged 12 and above, including adults and children. Nasal symptom relief begins within 15 minutes following the initial dose.
Who Are The Top Performing Companies In The Allergic Rhinitis Market In Recent Years?
Major companies operating in the allergic rhinitis market are Merck and Co. Inc., Bayer AG, Novartis AG, Sanofi-Aventis LLC., AstraZeneca PLC, GlaxoSmithKline plc., Boehringer Ingelheim International GmbH, Viatris Inc., Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., UCB S.A., Sun Pharmaceutical Industries Limited, Menarini Group, Perrigo Company PLC, Dr. Reddy’s Laboratories Ltd., Hikma Pharmaceuticals PLC, Cipla Limited, Endo Pharmaceuticals Inc., Zydus Lifesciences Ltd., Lupin Limited, Glenmark Pharma Ltd., Almirall S.A., Kyowa Kirin Co. Ltd., Hanmi Pharmaceutical Co. Ltd., Akorn Inc.
Download The Full Report For Exclusive Market Findings:
https://www.thebusinessresearchcompany.com/report/allergic-rhinitis-global-market-report
What Are The Regional Market Dynamics Impacting The Allergic Rhinitis Industry?
North America was the largest region in the allergic rhinitis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in allergic rhinitis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Request A Customized Version Of The Allergic Rhinitis Market Report:
https://www.thebusinessresearchcompany.com/customise?id=12926&type=smp
Browse Through More Reports Similar to the Global Allergic Rhinitis Market 2025, By The Business Research Company
Allergy Diagnostics Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/allergy-diagnostics-global-market-report
Allergy Conjunctivitis Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/allergy-conjunctivitis-global-market-report
House Dust Mite Allergy Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/house-dust-mite-allergy-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
